Nanostructured Silica Materials As Drug-Delivery Systems for Doxorubicin: Single Molecule and Cellular Studies-Reference-Cited by-同舟云学术

Nanostructured Silica Materials As Drug-Delivery Systems for Doxorubicin: Single Molecule and Cellular Studies

Published:2009-07-02 Issue:8 Volume:9 Page:2877-2883
ISSN:1530-6984
Container-title:Nano Letters
language:en
Short-container-title:Nano Lett.

Author:

Lebold Timo¹,Jung Christophe¹,Michaelis Jens¹,Bräuchle Christoph¹

Affiliation:

1. Department of Chemistry and Biochemistry, Center for Nanoscience (CeNS) and Center for Integrated Protein Science Munich (CIPSM), Ludwig-Maximilians-Universität München, Butenandtstrasse 11, Gerhard-Ertl-Building, 81377 Munich, Germany

Publisher

American Chemical Society (ACS)

Subject

Mechanical Engineering,Condensed Matter Physics,General Materials Science,General Chemistry,Bioengineering

Link

https://pubs.acs.org/doi/pdf/10.1021/nl9011112

Reference33 articles.

1. Clinical, toxicological and pharmaceutical aspects of the antineoplastic drug taxol: A review

2. Targeted cancer therapeutics: the heartbreak of success

3. New Methods of Drug Delivery

4. Micellar Nanocarriers: Pharmaceutical Perspectives

5. Polymeric Systems for Controlled Drug Release

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bridging the nano-Frontier: revolutionizing lung cancer diagnosis and therapy with nanoparticles;International Journal of Polymeric Materials and Polymeric Biomaterials;2024-06-18

2. Nanomedicine in infectious disease challenges and regulatory concerns;Nanostructured Drug Delivery Systems in Infectious Disease Treatment;2024

3. Controlled Release Study of Metformin Using Trithiocyanuric Acid Functionalized MCM‐41 as a Nanocarrier;ChemistrySelect;2023-12-11

4. Mucoadhesive Mesoporous Silica Particles as Versatile Carriers for Doxorubicin Delivery in Cancer Therapy;International Journal of Molecular Sciences;2023-09-28

5. Influence of Nanoscopic Micellar Confinements and Rotational Dynamics of Anticancer Drug Doxorubicin;PHYS CHEM RES;2023